Attached files
file | filename |
---|---|
EX-31.2 - EXHIBIT 31.2 - ASSEMBLY BIOSCIENCES, INC. | v460245_ex31-2.htm |
EX-32.1 - EXHIBIT 32.1 - ASSEMBLY BIOSCIENCES, INC. | v460245_ex32-1.htm |
10-K - FORM 10-K - ASSEMBLY BIOSCIENCES, INC. | v460245_10k.htm |
EX-32.2 - EXHIBIT 32.2 - ASSEMBLY BIOSCIENCES, INC. | v460245_ex32-2.htm |
EX-31.1 - EXHIBIT 31.1 - ASSEMBLY BIOSCIENCES, INC. | v460245_ex31-1.htm |
EX-23.1 - EXHIBIT 23.1 - ASSEMBLY BIOSCIENCES, INC. | v460245_ex23-1.htm |
EX-21 - EXHIBIT 21 - ASSEMBLY BIOSCIENCES, INC. | v460245_ex21.htm |
EX-10.12 - EXHIBIT 10.12 - ASSEMBLY BIOSCIENCES, INC. | v460245_ex10-12.htm |
EX-10.11 - EXHIBIT 10.11 - ASSEMBLY BIOSCIENCES, INC. | v460245_ex10-11.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of Assembly Biosciences, Inc. on Form S-3 (Nos. 333-200612 and 333-208806) and Form S-8 (Nos. 333-173613, 333-182167, 333-198803 and 333-213019) of our report dated March 12, 2015, on our audit of the consolidated financial statements for the year ended December 31 2014, which report is included in this Annual Report on Form 10-K to be filed on or about March 1, 2017.
/s/ EisnerAmper LLP | |
New York, New York | |
March 1, 2017 |